Ibuprofen 4% (w/v) Pivotal Bioequivalence Study

Clinical trial NCT03496324 · COMPLETED

Trial details

NCT number: NCT03496324
Sponsor: Reckitt Benckiser Healthcare (UK) Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bioequivalence of the Test Formulation

Start date: 2016-02-29
Primary completion: 2016-05-06
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.